JP2009526856A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526856A5
JP2009526856A5 JP2008555358A JP2008555358A JP2009526856A5 JP 2009526856 A5 JP2009526856 A5 JP 2009526856A5 JP 2008555358 A JP2008555358 A JP 2008555358A JP 2008555358 A JP2008555358 A JP 2008555358A JP 2009526856 A5 JP2009526856 A5 JP 2009526856A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555358A
Other languages
Japanese (ja)
Other versions
JP2009526856A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/004050 external-priority patent/WO2007095337A2/en
Publication of JP2009526856A publication Critical patent/JP2009526856A/ja
Publication of JP2009526856A5 publication Critical patent/JP2009526856A5/ja
Pending legal-status Critical Current

Links

JP2008555358A 2006-02-15 2007-02-15 抗体製剤 Pending JP2009526856A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77410106P 2006-02-15 2006-02-15
PCT/US2007/004050 WO2007095337A2 (en) 2006-02-15 2007-02-15 Antibody formulation

Publications (2)

Publication Number Publication Date
JP2009526856A JP2009526856A (ja) 2009-07-23
JP2009526856A5 true JP2009526856A5 (enExample) 2010-01-07

Family

ID=38372139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555358A Pending JP2009526856A (ja) 2006-02-15 2007-02-15 抗体製剤

Country Status (13)

Country Link
US (1) US20090306348A1 (enExample)
EP (1) EP1987067A4 (enExample)
JP (1) JP2009526856A (enExample)
KR (1) KR20080096827A (enExample)
CN (1) CN101495136A (enExample)
AU (1) AU2007215012A1 (enExample)
BR (1) BRPI0707796A2 (enExample)
CA (1) CA2642270A1 (enExample)
EA (1) EA200870264A1 (enExample)
IL (1) IL193408A0 (enExample)
MX (1) MX2008010562A (enExample)
NO (1) NO20083640L (enExample)
WO (1) WO2007095337A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883979B2 (en) 2012-08-31 2014-11-11 Bayer Healthcare Llc Anti-prolactin receptor antibody formulations

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090021298A (ko) * 2006-06-14 2009-03-02 임클론 시스템즈 인코포레이티드 항-ｅｇｆｒ 항체의 동결건조 제제
EP2527364A1 (en) 2007-03-29 2012-11-28 Abbott Laboratories Crystalline anti-human IL-12 antibodies
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
EP3011953A1 (en) * 2008-10-29 2016-04-27 Ablynx N.V. Stabilised formulations of single domain antigen binding molecules
EP2346900A1 (en) 2008-10-29 2011-07-27 Wyeth LLC Methods for purification of single domain antigen binding molecules
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
WO2011029823A1 (en) 2009-09-09 2011-03-17 Novartis Ag Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
EP2483301A1 (en) 2009-10-01 2012-08-08 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
AU2011234264B2 (en) 2010-03-31 2016-02-04 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material
US10206960B2 (en) 2010-03-31 2019-02-19 Stabilitech Biopharma Ltd Stabilisation of viral particles
HUE042330T2 (hu) 2010-03-31 2019-06-28 Stabilitech Biopharma Ltd Módszer alumínium adjuvánsok és alumíniummal adjuvált vakcinák megóvására
JP2013543384A (ja) 2010-10-05 2013-12-05 ノバルティス アーゲー 抗−ｉｌ１２ｒベータ１抗体ならびに自己免疫性および炎症性疾患の処置おけるその使用
TWI486617B (zh) * 2010-10-21 2015-06-01 Iner Aec Executive Yuan 一種測定對鎝（Ｔｃ－９９ｍ）與錸（Ｒｅ－１８６、Ｒｅ－１８８）具有穩定錯合力之含硫螯合劑在凍晶劑中之含量與均一性的固態樣品分析技術
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
SG11201402661TA (en) * 2011-11-28 2014-08-28 Phasebio Pharmaceuticals Inc Therapeutic agents comprising insulin amino acid sequences
US9029510B2 (en) 2012-03-30 2015-05-12 Sorrento Therapeutics, Inc. Fully human antibodies that bind to VEGFR2 and methods of use thereof
EP2830663B1 (en) * 2012-03-30 2019-02-06 Sorrento Therapeutics Inc. Fully human antibodies that bind to vegfr2
AP2015008584A0 (en) 2013-02-08 2015-07-31 Novartis Ag Anti-il-17a antibodies and their use in treating autoimmune and inflammatory disorders
US9700485B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
US20170291939A1 (en) 2014-06-25 2017-10-12 Novartis Ag Antibodies specific for il-17a fused to hyaluronan binding peptide tags
AR103173A1 (es) 2014-12-22 2017-04-19 Novarits Ag Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
SI3370768T1 (sl) 2015-11-03 2022-04-29 Janssen Biotech, Inc. Protitelesa, ki se specifično vežejo na PD-1, in njihove uporabe
BR112018014150A2 (en) 2016-01-11 2018-12-11 Novartis Ag immunostimulating humanized monoclonal antibodies to human interleukin-2, and fusion proteins thereof
CN106188296B (zh) * 2016-07-19 2018-05-08 康融东方（广东）医药有限公司 一类抗血管内皮生长因子受体vegfr2的单克隆抗体及其编码基因和应用
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
EP3684332A1 (en) * 2017-09-18 2020-07-29 Amgen Inc. Vegfr-fc fusion protein formulations
US12398209B2 (en) * 2018-01-22 2025-08-26 Janssen Biotech, Inc. Methods of treating cancers with antagonistic anti-PD-1 antibodies
MX2021009851A (es) 2019-02-18 2021-09-10 Lilly Co Eli Formulacion de anticuerpos terapeuticos.
CN110646618B (zh) * 2019-09-17 2022-11-01 广州市伊川生物科技有限公司 一种c反应蛋白测定试剂盒及其制备方法和应用
CN114980926A (zh) * 2020-02-21 2022-08-30 江苏恒瑞医药股份有限公司 一种抗il-4r抗体药物组合物及其用途
US11773160B1 (en) 2022-08-05 2023-10-03 Anaveon AG Immune-stimulating IL-2 fusion proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
EP0852951A1 (de) * 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
ATE454137T1 (de) * 2001-07-25 2010-01-15 Facet Biotech Corp Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab
WO2003068259A1 (fr) * 2002-02-14 2003-08-21 Chugai Seiyaku Kabushiki Kaisha Produits pharmaceutiques en solution contenant des anticorps

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883979B2 (en) 2012-08-31 2014-11-11 Bayer Healthcare Llc Anti-prolactin receptor antibody formulations

Similar Documents

Publication Publication Date Title
JP2009526856A5 (enExample)
CN300756617S (zh) 挂件(枫叶红玛瑙)
CN300727217S (zh) 多功能电子计步器
CN301078568S (zh) 自动售货直饮机
CN300727179S (zh) 包装袋(名補精藏)
CN300961291S (zh) 冰箱用抽屉开关装置
CN300932614S (zh) 发动机油底壳
CN300878187S (zh) 鞋子(91)
CN300726336S (zh) 沙发(主人位s-19)
CN300728416S (zh) 金卤灯(2)
CN300869052S (zh) 备用电池皮套(iphone型)
CN300727142S (zh) 包装袋(稗申)
CN300862423S (zh) 加热器面板(扇)
CN300861755S (zh) 开关电源(变压器差动装置)
CN300726688S (zh) 晒物架(旦型1)
CN300726616S (zh) 餐饮具(和谐三宝)
CN300856958S (zh) 雨伞
CN300854544S (zh) 沙发(920)
CN300847286S (zh) 床(实木801)
CN300726510S (zh) 椅座(0626-1)
CN300804194S (zh) 书本封套
CN300783158S (zh) 花布(07057a)
CN300767038S (zh) 电池挂卡
CN300762107S (zh) 针距调节器(1)
CN300729279S (zh) 气动扳手(89700一英寸)